Cargando…
Stakeholders’ Understanding of European Medicine Agency’s COVID-19 Vaccine Information Materials in EU and Regional Contexts
The COVID-19 pandemic posed challenges to communicating accurate information about vaccines because of the spread of misinformation. The European Medicines Agency (EMA) tried to reassure the public by communicating early on about the development and approval of COVID-19 vaccines. The EMA surveyed pa...
Autores principales: | Castro, Indiana, Van Tricht, Marie, Bonaccorso, Nicole, Sciortino, Martina, Garcia Burgos, Juan, Costantino, Claudio, Gonzalez-Quevedo, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610863/ https://www.ncbi.nlm.nih.gov/pubmed/37897018 http://dx.doi.org/10.3390/vaccines11101616 |
Ejemplares similares
-
Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy
por: Hines, Philip A., et al.
Publicado: (2020) -
Building organizational reputation in the European regulatory state: An analysis of EU agencies' communications
por: Rimkutė, Dovilė
Publicado: (2019) -
The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
por: Cavaleri, Marco, et al.
Publicado: (2021) -
Information exchange of law enforcement agencies within the EU in context of COVID 19 outbreak()
por: Kemény, Gábor, et al.
Publicado: (2023) -
Commentary on the European Medicines Agency's extended mandate: Protecting public health in times of crisis and improving availability of medicines and medical devices
por: Abed, Inga, et al.
Publicado: (2022)